Clinical Trial Update: Rapid Renal Sympathetic Denervation for Resistant Hypertension II [Phase 2, Phase 3]

View source ↗

Summary

Medtronic Endovascular's rapid renal sympathetic denervation trial for resistant hypertension (Phase 2/3) has been withdrawn. The trial was listed as withdrawn …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Resistant Hypertension

Snippet

Sponsor: Medtronic Endovascular | Conditions: Resistant Hypertension, Uncontrolled Hypertension | Phase 2, Phase 3 | Status: WITHDRAWN